These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 2615018)
41. Effects of azelastin on pruritus and plasma histamine levels in hemodialysis patients. Matsui C; Ida M; Hamada M; Morohashi M; Hasegawa M Int J Dermatol; 1994 Dec; 33(12):868-71. PubMed ID: 7883414 [TBL] [Abstract][Full Text] [Related]
42. [Immunological action of neurotropin (5). Effect of neurotropin on immunosuppression caused by stress]. Matsuoka T; Yoshii H; Suehiro S Nihon Yakurigaku Zasshi; 1987 Jul; 90(1):67-71. PubMed ID: 3653803 [TBL] [Abstract][Full Text] [Related]
43. Serum vitamin A levels and pruritus in patients on hemodialysis. de Kroes S; Smeenk G Dermatologica; 1983; 166(4):199-202. PubMed ID: 6852332 [TBL] [Abstract][Full Text] [Related]
44. [Favorable effect of nicergoline on pruritus in chronic hemodialysis patients. Role of a hyper-alpha-adrenergic system?]. Rivory JP; Maheut H Presse Med; 1984 Dec; 13(44):2703. PubMed ID: 6096843 [No Abstract] [Full Text] [Related]
45. Increased met-enkephalin plasma levels in hemodialysis patients with or without pruritus. Danno K; Nishiura K; Tanaka M J Dermatol Sci; 1995 Nov; 10(3):238-40. PubMed ID: 8593268 [TBL] [Abstract][Full Text] [Related]
46. Neurotropin treatment of brain edema accompanying acute middle cerebral artery infarction. De Reuck J; Decoo D; Boon P; Van der Linden C Acta Neurochir Suppl (Wien); 1994; 60():332-4. PubMed ID: 7976582 [TBL] [Abstract][Full Text] [Related]
47. Relief of chronic burning pain in Fabry disease with neurotropin. Inagaki M; Ohno K; Ohta S; Sakuraba H; Takeshita K Pediatr Neurol; 1990; 6(3):211-3. PubMed ID: 2113806 [TBL] [Abstract][Full Text] [Related]
48. Crotamiton lotion in pruritus. Smith EB; King CA; Baker MD Int J Dermatol; 1984 Dec; 23(10):684-5. PubMed ID: 6396248 [TBL] [Abstract][Full Text] [Related]
49. Cutaneous manifestations of COVID-19: An unusual presentation with edematous plaques and pruritic, erythematous papules, and comment on the role of bradykinin storm and its therapeutic implications. Kroumpouzos G Dermatol Ther; 2021 Mar; 34(2):e14753. PubMed ID: 33406308 [No Abstract] [Full Text] [Related]
50. Difelikefalin in Hemodialysis Patients with Pruritus. Lin CH N Engl J Med; 2020 May; 382(21):2064-2065. PubMed ID: 32433847 [No Abstract] [Full Text] [Related]
51. Difelikefalin in Hemodialysis Patients with Pruritus. Manenti L; Rossi GM; Fiaccadori E N Engl J Med; 2020 May; 382(21):2064. PubMed ID: 32433846 [No Abstract] [Full Text] [Related]
52. Difelikefalin in Hemodialysis Patients with Pruritus. Brennan F; Davison S; Brown M N Engl J Med; 2020 May; 382(21):2064. PubMed ID: 32433845 [No Abstract] [Full Text] [Related]
53. Hair Loss in a Hemodialysis Patient after Repetitive Use of the Antipruritic Drug Nalfurafine: Implications of Impaired Angiogenesis for Hair Loss. Kida Y; Itoh S; Yoshimi S; Kobayashi Y; Izumi M Intern Med; 2024 Oct; ():. PubMed ID: 39401915 [TBL] [Abstract][Full Text] [Related]
54. Difelikefalin in Hemodialysis Patients with Pruritus. Reply. Fishbane S N Engl J Med; 2020 May; 382(21):2065-2066. PubMed ID: 32433848 [No Abstract] [Full Text] [Related]
56. Pruritus as a Patient-Reported Primary Trial End Point in Hemodialysis: Evaluation and Implications. Nair D; Finkelstein FO Am J Kidney Dis; 2020 Jul; 76(1):148-151. PubMed ID: 32334827 [No Abstract] [Full Text] [Related]
57. The Complement System in Hemodialysis Patients: Getting to the Heart of the Matter. de Borst MH Nephron; 2016; 132(1):1-4. PubMed ID: 26745820 [No Abstract] [Full Text] [Related]